Vivorte

About Vivorte

Vivorte specializes in developing advanced bone grafting and regenerative technologies aimed at improving surgical outcomes for surgeons, hospitals, and patients. The company operates in the medical device and biotechnology market, focusing on creating proprietary products like Fortera and Trabexus. Fortera is a self-setting, injectable calcium phosphate cement designed for bone void filling applications that require high compressive strength and minimally invasive delivery. Trabexus is a self-setting, gradually resorbable calcium phosphate cement combined with engineered bone particles to optimize compressive strength and resorptive characteristics. Vivorte's business model includes partnerships with distributors like Acumed to expand its market reach and ensure exclusive distribution of its orthobiologics portfolio. The company generates revenue through the sale of its innovative bone grafting materials to healthcare providers and institutions.